The research conducted at Ahammune has led us to identify cellular pathways deregulated in vitiligo. Our strategy is to restore these pathways to their homeostatic state using small molecules to maintain skin health.
Our molecules tackle the problem of new immune triggers where melanocyte killing is done by effector T cells. By targeting the activation step of immune cells, our molecules prevent further killing and spread of depigmentation.
If science is your passion and translation your goal, join us. At Ahammune, we seek people who love innovating and thrive on challenges- with the ultimate mission to impact people’s lives.